142
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Risk Factors and Disease Profile Associated with the Nucleic Acid Conversion Time of COVID-19 Patients Infected with the SARS-CoV-2 Omicron Variant in Fangcang Shelter Hospitals

ORCID Icon, ORCID Icon, ORCID Icon, , &
Pages 3945-3954 | Received 10 Mar 2023, Accepted 15 Jun 2023, Published online: 20 Jun 2023

References

  • Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–160. doi:10.23750/abm.v91i1.9397
  • Del Rio C, Omer SB, Malani PN. Winter of omicron-the evolving COVID-19 pandemic. JAMA. 2022;327(4):319–320. doi:10.1001/jama.2021.24315
  • Dandan T, Yanhong S, Huihong X, et al. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J Med Virol. 2022;94:2376–2383. doi:10.1002/jmv.27643
  • Annika R, Lydia R, David B, et al. SARS-CoV-2 omicron variant neutralization in serum from vaccinated and convalescent persons. N Engl J Med. 2022;386:698–700. doi:10.1056/NEJMc2119236
  • Choudhary Om Prakash P, Indraj S, Singh I, et al. Aerosol transmission of SARS-CoV-2: the unresolved paradox. Travel Med Infect Dis. 2020;37:101869. doi:10.1016/j.tmaid.2020.101869
  • Simiao C, Zongjiu Z, Juntao Y, et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet. 2020;395:1305–1314. doi:10.1016/S0140-6736(20)30744-3
  • Shang L, Xu J, Cao B. Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance. Clin Microbiol Infect. 2020;26:976–978. doi:10.1016/j.cmi.2020.04.038
  • Saeed K, Ali G, Gholamreza M, et al. Post-hospital discharge strategy for COVID-19 treatment and control: focus on Fangcang hospitals. Disaster Med Public Health Prep. 2022;16:1795–1797. doi:10.1017/dmp.2021.83
  • Jianguo Z, Nan C, Daguo Z, et al. Clinical characteristics of COVID-19 patients infected by the omicron variant of SARS-CoV-2. Front Med. 2022;9:912367. doi:10.3389/fmed.2022.912367
  • Michela A, Penfold Rose S, Jordi M, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43–55. doi:10.1016/S1473-3099(21)00460-6
  • Jingwen A, Haocheng Z, Yi Z, et al. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost. Emerg Microbes Infect. 2022;11:337–343. doi:10.1080/22221751.2021.2022440
  • Choudhary OP. Vaccine efficacy against COVID-19: a foresight on the host-associated factors. J Formos Med Assoc. 2021;120:1405–1407. doi:10.1016/j.jfma.2020.11.021
  • Om Prakash C, Singh I. Making sound public health policy decisions for COVID-19 vaccination: vaccine effectiveness, safety, affordability, programmatic logistics and roll-out globally. J Travel Med. 2021;taab031. doi:10.1093/jtm/taab031
  • Xuefeng M, Shousheng L, Lizhen C, et al. The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: a meta-analysis and systematic review. J Med Virol. 2021;93:234–240. doi:10.1002/jmv.26208
  • Hongye W, Dongshan Y, Ya L, et al. Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients. Infect Dis Poverty. 2022;11:15. doi:10.1186/s40249-022-00940-w
  • Youjiang L, Danping J, Wangyu C, et al. Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid repositive patients: a literature review. J Med Virol. 2021;93:1288–1295. doi:10.1002/jmv.26491
  • Abdulrahman A, Waleed A, Fahad F, et al. Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: a retrospective study. J Epidemiol Glob Health. 2021;11:98–104. doi:10.2991/jegh.k.200928.001
  • Bo Y, Gaoke F, Dedong C, et al. Epidemiological and clinical characteristics of 214 families with COVID-19 in Wuhan China. Int J Infect Dis. 2021;105:113–119. doi:10.1016/j.ijid.2021.02.021
  • Bin H, Wei C, Tingyu Y, et al. Study on the localization of fangcang shelter hospitals during pandemic outbreaks. Front Public Health. 2022;10:876558. doi:10.1016/j.ijid.2021.02.021
  • Xin Z, Liangkun X, Junyao Z, et al. The value of early positive nucleic acid test and negative conversion time of SARS-CoV-2 RNA in the clinical outcome of COVID-19 patients. Front Med. 2022;9:826900. doi:10.3389/fmed.2022.826900
  • Pingzheng M, Liping D, Xiaoping L, et al. Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study. Epidemiol Infect. 2020;148:e293. doi:10.1017/S0950268820002940
  • Kuldeep D, Shailesh Kumar P, Senthilkumar N, et al. COVID-19 in the elderly people and advances in vaccination approaches. Hum Vaccin Immunother. 2020;16:2938–2943. doi:10.1080/21645515.2020.1842683
  • Julia H-C, Martina P, Mei Xue W, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021;374:n1931. doi:10.1136/bmj.n1931
  • Soiza Roy L, Chiara S, Thomson Emma C. Efficacy and safety of COVID-19 vaccines in older people. Age Ageing. 2021;50:279–283. doi:10.1093/ageing/afaa274
  • Xiaowen H, Yuhan X, Jing J, et al. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. Sci Total Environ. 2020;728:138812. doi:10.1016/j.scitotenv.2020.138812